199 related articles for article (PubMed ID: 22094461)
1. Phospholipase D2 (PLD2) shortens the time required for myeloid leukemic cell differentiation: mechanism of action.
Di Fulvio M; Frondorf K; Henkels KM; Grunwald WC; Cool D; Gomez-Cambronero J
J Biol Chem; 2012 Jan; 287(1):393-407. PubMed ID: 22094461
[TBL] [Abstract][Full Text] [Related]
2. Mammalian target of rapamycin (mTOR) and S6 kinase down-regulate phospholipase D2 basal expression and function.
Tabatabaian F; Dougherty K; Di Fulvio M; Gomez-Cambronero J
J Biol Chem; 2010 Jun; 285(25):18991-9001. PubMed ID: 20410302
[TBL] [Abstract][Full Text] [Related]
3. Phospholipase D2-derived phosphatidic acid binds to and activates ribosomal p70 S6 kinase independently of mTOR.
Lehman N; Ledford B; Di Fulvio M; Frondorf K; McPhail LC; Gomez-Cambronero J
FASEB J; 2007 Apr; 21(4):1075-87. PubMed ID: 17242159
[TBL] [Abstract][Full Text] [Related]
4. A new signaling pathway (JAK-Fes-phospholipase D) that is enhanced in highly proliferative breast cancer cells.
Ye Q; Kantonen S; Henkels KM; Gomez-Cambronero J
J Biol Chem; 2013 Apr; 288(14):9881-9891. PubMed ID: 23404507
[TBL] [Abstract][Full Text] [Related]
5. New concepts in phospholipase D signaling in inflammation and cancer.
Gomez-Cambronero J
ScientificWorldJournal; 2010 Jul; 10():1356-69. PubMed ID: 20623096
[TBL] [Abstract][Full Text] [Related]
6. Phosphatidic acid is a leukocyte chemoattractant that acts through S6 kinase signaling.
Frondorf K; Henkels KM; Frohman MA; Gomez-Cambronero J
J Biol Chem; 2010 May; 285(21):15837-47. PubMed ID: 20304930
[TBL] [Abstract][Full Text] [Related]
7. The exquisite regulation of PLD2 by a wealth of interacting proteins: S6K, Grb2, Sos, WASp and Rac2 (and a surprise discovery: PLD2 is a GEF).
Gomez-Cambronero J
Cell Signal; 2011 Dec; 23(12):1885-95. PubMed ID: 21740967
[TBL] [Abstract][Full Text] [Related]
8. The molecular basis of phospholipase D2-induced chemotaxis: elucidation of differential pathways in macrophages and fibroblasts.
Knapek K; Frondorf K; Post J; Short S; Cox D; Gomez-Cambronero J
Mol Cell Biol; 2010 Sep; 30(18):4492-506. PubMed ID: 20647543
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
[TBL] [Abstract][Full Text] [Related]
10. Deregulated phospholipase D2/mammalian target of rapamycin/hypoxia-inducible factor 1 alpha in peripheral T lymphocytes of oral lichen planus correlated with disease severity.
Wang F; Zhang J; Zhou G
Arch Oral Biol; 2019 Feb; 98():26-31. PubMed ID: 30419486
[TBL] [Abstract][Full Text] [Related]
11. Novel functions of the phospholipase D2-Phox homology domain in protein kinase Czeta activation.
Kim JH; Kim JH; Ohba M; Suh PG; Ryu SH
Mol Cell Biol; 2005 Apr; 25(8):3194-208. PubMed ID: 15798205
[TBL] [Abstract][Full Text] [Related]
12. Target of rapamycin (TOR) controls vitellogenesis via activation of the S6 kinase in the fat body of the tick, Haemaphysalis longicornis.
Umemiya-Shirafuji R; Boldbaatar D; Liao M; Battur B; Rahman MM; Kuboki T; Galay RL; Tanaka T; Fujisaki K
Int J Parasitol; 2012 Oct; 42(11):991-8. PubMed ID: 22985802
[TBL] [Abstract][Full Text] [Related]
13. PLD2 forms a functional complex with mTOR/raptor to transduce mitogenic signals.
Ha SH; Kim DH; Kim IS; Kim JH; Lee MN; Lee HJ; Kim JH; Jang SK; Suh PG; Ryu SH
Cell Signal; 2006 Dec; 18(12):2283-91. PubMed ID: 16837165
[TBL] [Abstract][Full Text] [Related]
14. Activation of RBL-2H3 mast cells is dependent on tyrosine phosphorylation of phospholipase D2 by Fyn and Fgr.
Choi WS; Hiragun T; Lee JH; Kim YM; Kim HP; Chahdi A; Her E; Han JW; Beaven MA
Mol Cell Biol; 2004 Aug; 24(16):6980-92. PubMed ID: 15282299
[TBL] [Abstract][Full Text] [Related]
15. Sustained PKCĪ²II activity confers oncogenic properties in a phospholipase D- and mTOR-dependent manner.
El Osta M; Liu M; Adada M; Senkal CE; Idkowiak-Baldys J; Obeid LM; Clarke CJ; Hannun YA
FASEB J; 2014 Jan; 28(1):495-505. PubMed ID: 24121461
[TBL] [Abstract][Full Text] [Related]
16. Expression and regulation of phospholipase D isoforms in mammalian cell lines.
Gibbs TC; Meier KE
J Cell Physiol; 2000 Jan; 182(1):77-87. PubMed ID: 10567919
[TBL] [Abstract][Full Text] [Related]
17. Src homology 2 domain substitution modulates the kinase and transforming activities of the Fes protein-tyrosine kinase.
Rogers JA; Cheng HY; Smithgall TE
Cell Growth Differ; 2000 Nov; 11(11):581-92. PubMed ID: 11095247
[TBL] [Abstract][Full Text] [Related]
18. Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin.
Toschi A; Lee E; Xu L; Garcia A; Gadir N; Foster DA
Mol Cell Biol; 2009 Mar; 29(6):1411-20. PubMed ID: 19114562
[TBL] [Abstract][Full Text] [Related]
19. Elevated expression of the c-fes proto-oncogene in adult human myeloid leukemia cells in the absence of gene amplification.
Smithgall TE; Johnston JB; Bustin M; Glazer RI
J Natl Cancer Inst; 1991 Jan; 83(1):42-6. PubMed ID: 1984516
[TBL] [Abstract][Full Text] [Related]
20. Activation of Raf-1 and mitogen-activated protein kinases during monocytic differentiation of human myeloid leukemia cells.
Kharbanda S; Saleem A; Emoto Y; Stone R; Rapp U; Kufe D
J Biol Chem; 1994 Jan; 269(2):872-8. PubMed ID: 8288641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
